Details of the Drug Combinations

General Information of This Drug (ID: DMR1WBZ)

Drug Name

Lithium Carbonate DMR1WBZ

Synonyms

Lithobid; Eskalith; Eskalith Cr; Lithane; Lithotabs

Indication

Disease Entry	ICD 11	Status	REF
Manic depression disorder	6A71	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

4 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Lamotrigine + Lithium Carbonate	DC1VUOM	Lamotrigine	Bipolar Disorder	[2]
Lithium Carbonate + Venlafaxine	DC1SKJ7	Venlafaxine	Depressive Disorder, Major	[3]
Lithium Carbonate + Valproic Acid	DCMYYA0	Valproic Acid	Bipolar Disorder	[2]
Ketamine + Lithium Carbonate	DCPJEPA	Ketamine	Treatment Resistant Depression	[4]
------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	ClinicalTrials.gov (NCT00221975) Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling
3	ClinicalTrials.gov (NCT00627887) Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of Depression
4	ClinicalTrials.gov (NCT03290963) Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine